.

0 (hodnocen0 x )

BK

5th edition

Lyon : International Agency for Research on Cancer, 2019

356 stran : barevné ilustrace ; 27 cm

ISBN 978-92-832-4500-1 (brožováno)

WHO classification of tumours ; Vol. 2

"edited by the WHO Classification of Tumours Editoral Board"--Obálka

Obsahuje bibliografii na stranách 311-347 a rejstřík

001484804

Contents // _st of abbreviations reword // TNM staging of carcinomas of the breast - Introduction to tumours of the breast // 2 Epithelial tumours of the breast // .7HO classification of epithelial tumours of the breast Benign epithelial proliferations and precursors Introduction // Usual ductal hyperplasia // Columnar cell lesions, including flat epithelial atypia Atypical ductal hyperplasia Adenosis and benign sclerosing lesions Introduction Sclerosing adenosis Apocrine adenosis and adenoma Microglandular adenosis Radial scar / complex sclerosing lesion Adenomas Introduction Tubular adenoma Lactating adenoma Ductal adenoma Epithelial-myoepithelial tumours Introduction Pleomorphic adenoma Adenomyoepithelioma Malignant adenomyoepithelioma Papillary neoplasms Introduction Intraductal papilloma Papillary ductal carcinoma in situ Encapsulated papillary carcinoma Solid papillary carcinoma (in situ and invasive) Invasive papillary carcinoma Non-invasive lobular neoplasia Introduction // Atypical lobular hyperplasia Lobular carcinoma in situ Ductal carcinoma in situ Introduction // Ductal carcinoma in situ Invasive breast carcinoma General overview // Invasive breast carcinoma of no special type // Microinvasive carcinoma // Invasive lobular carcinoma // Tubular carcinoma // Cribriform carcinoma // Mucinous carcinoma // Mucinous cystadenocarcinoma // Invasive micropapillary carcinoma // Carcinoma with apocrine differentiation // Metaplastic carcinoma // ix Rare and salivary gland-type

tumours // Introduction 139 // X Acinic cell carcinoma 139 // Adenoid cystic carcinoma 142 // 1 Secretory carcinoma 146 // Mucoepidermoid carcinoma 149 // 5 Polymorphous adenocarcinoma 151 // Tall cell carcinoma with reversed polarity 153 // 9 Neuroendocrine neoplasms // 10 Introduction 155 // Neuroendocrine tumour 156 // 11 Neuroendocrine carcinoma 159 // 13 15 3 Fibroepithelial tumours and hamartomas of the breast 163 // 18 WHO classification of fibroepithelial tumours and // hamartomas of the breast 164 // 22 Introduction 165 // 22 Hamartoma 166 // 25 Fibroadenoma 168 // 28 Phyllodes tumour 172 // 30 // 4 Tumours of the nipple 177 // 32 WHO classification of tumours of the nipple 178 // 32 Introduction 179 // 35 Epithelial tumours // 37 Syringomatous tumour 180 // Nipple adenoma 182 // 39 Paget disease of the breast 184 // 40 // 43 5 Mesenchymal tumours of the breast 187 // 46 WHO classification of mesenchymal tumours of the breast 188 // Introduction 189 // 49 Vascular tumours // 52 Haemangioma 191 // 57 Angiomatosis 193 // 60 Atypical vascular lesions 195 // 63 Postradiation angiosarcoma of the breast 197 // 66 Primary angiosarcoma of the breast 200 // Fibroblastic and myofibroblastic tumours // 68 Nodular fasciitis 202 // 68 Myofibroblastoma 204 // 71 Desmoid fibromatosis 206 // Inflammatory myofibroblastic tumour 209 // 75 Peripheral nerve sheath tumours // 76 Schwannoma 211 // Neurofibroma 213 // 82 Granular cell tumour 215 // 102 Smooth muscle tumours

// 110 Leiomyoma 217 // 114 Leiomyosarcoma 219 // 119 Adipocytic tumours // 121 Lipoma 221 // 123 Angiolipoma 223 // 126 Liposarcoma 225 // 128 Other mesenchymal tumours and tumour-like conditions // 131 Pseudoangiomatous stromal hyperplasia 228 // 134 // 6 Haematolymphoid tumours of the breast 231 // WHO classification of haematolymphoid tumours // of the breast 232 // Introduction 233 // Lymphoma // Extranodal marginal zone lymphoma of mucosa- // associated lymphoid tissue (MALT lymphoma) 235 // Follicular lymphoma 238 // Diffuse large ?-cell lymphoma 240 // Burkitt lymphoma 242 // Breast implant-associated anaplastic large cell // lymphoma 245 // 7 Tumours of the male breast 249 // WHO classification of tumours of the male breast 250 // Introduction 251 // Epithelial tumours // Gynaecomastia 252 // Carcinoma in situ 255 // Invasive carcinoma 257 // 8 Metastases to the breast 261 // 9 Genetic tumour syndromes of the breast 267 // Introduction 268 // ?RCA1/2-associateci hereditary breast and ovarian cancer // syndrome 270 // Cowden syndrome 275 // Ataxia-telangiectasia 277 // Li-Fraumeni syndrome, 7P53-associated 279 // Li-Fraumeni syndrome, CHEK2-assoc\ateó 282 // CDH1-associated breast cancer 284 // PALB2-assoclated cancers 286 // Peutz-Jeghers syndrome 288 // Neurofibromatosis type 1 290 // The polygenic component of breast cancer susceptibility 292 // Contributors 299 // Declaration of interests 305 // IARC/WHO Committee for ICD-0 306 // Sources 307 // References 311

// Subject index 349 // Previous volumes in the series 356